Daniel Thomas

Promising trial data for onvansertib offers new hope for colorectal cancer patients, yet leadership changes and financial hurdles cloud the path forward.

Cutting Horse, led by operators behind billion-dollar brands, exceeds its target to deploy capital and hands-on expertise to founder-led businesses.

Amidst industry-wide regulatory challenges, Meridian secures critical IVDR certification for its Alethia assays, ensuring continued market access in Europe.

A new platform, Venn.ai, promises to let AI take real action in business apps, but with a critical feature: a human-in-the-loop safety switch.

The fusion energy pioneer plans to go public via a SPAC merger, seeking capital to prove its unique technology and win the race for limitless clean power.

Tired of juggling multiple health portals? Pixel Health's new AI-powered platform, One Thread, aims to unify the patient journey into a single experience.

A new state-backed decal helps consumers spot legal cannabis sellers. Discover how the 'Verified Dispensary' program aims to ensure safety and combat illicit sales.

Arrotex secures rights to an innovative, FDA-approved nanotech eye drop, promising faster, simpler recovery for thousands of surgical patients.

New York's 2026 housing market opens with a puzzle: sales are down 7.5%, yet the median home price soars to $445,000. Who can still afford to buy?

After 35 years of advocacy, David Suzuki challenges corporate Canada to lead on climate, framing action as the ultimate source of hope for the future.

A new subcontract for AI edge systems, backed by key industry investors, highlights a major shift toward real-time, autonomous intelligence on the battlefield.

With a fresh $40.2M, Phoenix Tailings accelerates its mission to build a secure, domestic rare earth supply chain, crucial for tech and defense.

Fox Corporation will double the government's $1,000 'Trump Account' deposit for employees' children, a move lauded as a benefit but also raising questions.

A new partnership between Invisalign and DanceOne signals a major shift in youth marketing, blending oral health with artistic confidence on the dance floor.

A tech CEO's call for Apple to recognize sacred Christian names like 'Yeshua' sparks a debate on digital inclusion, corporate responsibility, and faith.

With a major €12.5M EU funding package, Step Pharma is fast-tracking dencatistat, a novel therapy targeting a key vulnerability in ovarian and endometrial cancers.

As Signet prepares its Q4 earnings, all eyes are on whether its brand power can overcome cautious consumer spending and set the tone for the luxury market.

A new partnership turns agricultural waste into high-value carbon credits, boosting soil health and creating jobs in West Africa's cashew heartland.

A class action lawsuit reveals a massive pump-and-dump scheme targeting China Liberal Education, raising questions of corporate complicity and investor recourse.

The new real estate powerhouse's stunning inaugural year validates its consolidation strategy and signals a recovery for the commercial net lease sector.